| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.66▼ | 4.66▼ | 4.66▼ | 4.59▼ | 4.57▼ |
| MA10 | 4.75▼ | 4.74▼ | 4.73▼ | 4.58▼ | 4.63▼ |
| MA20 | 4.74▼ | 4.75▼ | 4.74▼ | 4.63▼ | 4.67▼ |
| MA50 | 4.77▼ | 4.76▼ | 4.73▼ | 4.69▼ | 4.58▼ |
| MA100 | 4.65▼ | 4.59▲ | 4.56▲ | 4.70▼ | 4.33▲ |
| MA200 | 4.45▲ | 4.44▲ | 4.53▲ | 4.50▼ | 4.52▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.018▼ | -0.018▼ | -0.018▼ | -0.003▼ | -0.037▼ |
| RSI | 39.482▼ | 40.785▼ | 42.274▼ | 39.228▼ | 45.791▼ |
| STOCH | 30.382 | 30.382 | 30.382 | 39.528 | 15.335▼ |
| WILL %R | -89.583▼ | -89.583▼ | -89.583▼ | -100.000▼ | -100.000▼ |
| CCI | -106.289▼ | -102.931▼ | -113.488▼ | -131.246▼ | -116.074▼ |
| RSI | $ELSE RSI(14) Crossed Below 50 | Set Alert |
| ▼ MACD | $ELSE MACD(12,26,9) Crossed Below Signal Line | Set Alert |
| MA | $ELSE Price Crossed Below MA(200) | Set Alert |
| MA | $ELSE Price Crossed Below MA(26) | Set Alert |
| MA | $ELSE Price Crossed Below MA(13) | Set Alert |
| MA | $ELSE Price Crossed Below MA(7) | Set Alert |
| ▼ GAP | $ELSE Open Gap Down %3 | Set Alert |
| ▼ GAP | $ELSE Open Gap Down %2 | Set Alert |
| ▼ BREAK | $ELSE Price Breaks 60 Days Low | Set Alert |
| ▼ BREAK | $ELSE Price Breaks 30 Days Low | Set Alert |
| ▼ BREAK | $ELSE Price Breaks 20 Days Low | Set Alert |
| ▼ BREAK | $ELSE Price Breaks 10 Days Low | Set Alert |
|
Thursday, September 11, 2025 04:25 PM
VANCOUVER, BC, Sept. 11, 2025 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"), today announced that it plans to host a business update conference call at ...
|
|
Friday, August 01, 2025 08:38 AM
VANCOUVER, BC, Aug. 1, 2025 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) (the "Company") announces that further to its news release dated June 19, 2025, the ...
|
|
Tuesday, July 22, 2025 04:00 AM
FDA Directed to Streamline Approval Pathways for Plant-Based Infant Formulas, Positioning Else Nutrition to Capitalize on Legislative Momentum and Rising Consumer Demand The accompanying report ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/12/25 | 4.51 | 4.64 | 4.48 | 4.48 | 3,921 |
| 09/12/25 | 4.68 | 4.68 | 4.66 | 4.68 | 509 |
| 08/12/25 | 4.632 | 4.70 | 4.57 | 4.58 | 6,236 |
| 04/12/25 | 4.605 | 4.605 | 4.60 | 4.60 | 317 |
| 03/12/25 | 4.60 | 4.6069 | 4.60 | 4.6069 | 683 |
| 01/12/25 | 4.56 | 4.56 | 4.56 | 4.56 | 230 |
| 28/11/25 | 4.53 | 4.53 | 4.53 | 4.53 | 176 |
| 26/11/25 | 4.65 | 4.6642 | 4.61 | 4.61 | 2,821 |
| 25/11/25 | 4.52 | 4.60 | 4.52 | 4.60 | 1,920 |
| 24/11/25 | 4.56 | 4.59 | 4.56 | 4.5898 | 3,992 |
|
|
||||
|
|
||||
|
|